Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Patients on mood stabilizers need regular health checks, but many aren't monitored properly.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Dermatologists are key in detecting and managing OCD and BFRBs by working with psychiatrists.

Trichodaganomania involves biting one's hair and needs combined psychological and medical treatment.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

The screening method effectively predicts psychosis, valproate use is linked to hair loss, and IDEAS is valid for assessing mental disorder disability.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

A certain surfactant sticks to human hair, making it change from water-repelling to water-attracting, which could help in hair conditioning.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

A brain injury can lead to compulsive hair-pulling and psychosis-like symptoms, needing comprehensive treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Trichotillomania can occur in unusual patterns and sites, highlighting the need for awareness and treatment options.

Combining online and in-person dermatology care can improve quality and access.

BDNF, TSH, fT4, anti-TPO, and 25-OH Vitamin D levels predict depression risk in patients with autoimmune thyroiditis and hypothyroidism.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Effective treatments for trichotillomania include cognitive-behavioral therapy, certain medications, and alternative support tools.

Individualized treatments may help manage Dercum's disease symptoms.

Botulinum toxin may help treat male pattern baldness.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.